Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells
- PMID: 36695530
- DOI: 10.1080/02713683.2023.2173237
Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells
Abstract
Purpose: In the last few decades, several blood derived products such as platelet-rich plasma (PRP), plasma rich in growth factors (PRGF) and autologous serum (AS) have been used for the treatment of ocular surface disorders. Recently, insulin has been proposed to be used as an alternative for the treatment of ocular surface diseases. The aim of this study was to evaluate the biological potential of PRGF eye drops in comparison with AS and insulin on ocular surface cells.
Methods: Blood from three healthy young donors was collected to obtain autologous serum (AS) eye drops and plasma rich in growth factors (PRGF) eye drops. Insulin (Actrapid®) was diluted at 1 and 0.2 IU/mL. The biological potential of PRGF, AS and insulin was assessed by proliferation in HCE, HK and HConF cells. Wound healing assay was performed in HCE cells after incubation with the different treatments. HConF and HK cells were differentiated to myofibroblast after treatment with 2.5 ng/mL of TGF-β1 and then incubated with all treatments.
Results: PRGF eye drops induced significantly higher proliferation rate compared to AS or insulin in HConF and HK cells, but not in HCE cells. In addition, the percentage of wound healing area was significantly reduced after PRGF treatment in comparison with AS or insulin treatment. Furthermore, PRGF significantly reduced the number of myodifferentiated cells compared to AS and insulin at both concentrations analyzed.
Conclusion: The results obtained in the present study show that PRGF increases the biological activity of the ocular surface cells and reduces the expression of fibrosis marker compared to insulin or AS.
Translational relevance: The present study suggests that plasma rich in growth factors eye drops are a more effective therapy than insulin and autologous serum eye drops for the treatment of ocular surface diseases.
Keywords: Cornea; epithelial cells; fibroblasts; platelet rich plasma; wound healing.
Similar articles
-
Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.Exp Eye Res. 2015 Jun;135:118-26. doi: 10.1016/j.exer.2015.02.016. Epub 2015 Feb 21. Exp Eye Res. 2015. PMID: 25708868
-
Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.Exp Eye Res. 2014 Feb;119:27-34. doi: 10.1016/j.exer.2013.12.005. Epub 2013 Dec 15. Exp Eye Res. 2014. PMID: 24345372
-
PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.Exp Eye Res. 2016 Oct;151:115-21. doi: 10.1016/j.exer.2016.08.012. Epub 2016 Aug 25. Exp Eye Res. 2016. PMID: 27567559 Review.
-
Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum.Int J Mol Sci. 2021 Nov 10;22(22):12176. doi: 10.3390/ijms222212176. Int J Mol Sci. 2021. PMID: 34830053 Free PMC article.
-
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus.Expert Opin Biol Ther. 2022 Jan;22(1):31-45. doi: 10.1080/14712598.2021.1945030. Epub 2021 Jul 19. Expert Opin Biol Ther. 2022. PMID: 34275392 Review.
Cited by
-
Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.Ophthalmol Ther. 2025 Sep;14(9):2253-2281. doi: 10.1007/s40123-025-01211-1. Epub 2025 Jul 25. Ophthalmol Ther. 2025. PMID: 40715787
-
Autologous blood in the management of ocular surface disorders.World J Exp Med. 2024 Dec 20;14(4):96412. doi: 10.5493/wjem.v14.i4.96412. eCollection 2024 Dec 20. World J Exp Med. 2024. PMID: 39713083 Free PMC article. Review.
-
Effect of autologous serum after amniotic membrane transplantation for persistent corneal ulcers.Int J Ophthalmol. 2024 Sep 18;17(9):1639-1644. doi: 10.18240/ijo.2024.09.10. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39296570 Free PMC article.
-
Safety of intraoperative autologous plasma incubation of corneal grafts for reducing endothelial cell loss: a pilot study.Front Med (Lausanne). 2024 Aug 12;11:1368117. doi: 10.3389/fmed.2024.1368117. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39188872 Free PMC article.
-
Platelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis.Int J Mol Sci. 2025 Jul 15;26(14):6782. doi: 10.3390/ijms26146782. Int J Mol Sci. 2025. PMID: 40725031 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials